Hermetica Superfood Encyclopedia
The Short Answer
Abuta root contains isoquinoline alkaloids—principally hayatinine, magnocurarine, cissamine, magnoflorine, and the bisbenzylisoquinoline tetrandrine—that inhibit Plasmodium falciparum replication and suppress dengue virus replication post-cell entry. In vitro, the root hydroethanolic extract achieved antiplasmodial IC50 values of 1.15–1.42 μg/ml against both chloroquine-sensitive (Pf3D7) and resistant (PfINDO) strains, while an in vivo mouse dengue model at 250 mg/kg twice daily yielded approximately 67% survival versus placebo (p=0.021).
CategoryRoot
GroupAmazonian
Evidence LevelPreliminary
Primary Keywordabuta benefits
Abuta — botanical close-up
Health Benefits
**Antiplasmodial Activity**
The isolated alkaloid hayatinine exhibits potent inhibition of Plasmodium falciparum growth with IC50 values of 0.41 μM (PfINDO) and 0.509 μM (Pf3D7), outperforming co-isolated alkaloids magnocurarine and cissamine in vitro and suggesting a root-derived lead compound for antimalarial drug development.
**Antiviral Action Against Dengue**
Alcoholic root extracts suppress all four dengue virus serotypes (DENV-1 to DENV-4) post-cell entry with IC50 values ranging from 78–125 μg/ml in plaque reduction assays, reducing NS1 antigen secretion and viral plaque formation without significant cytotoxicity at active concentrations.
**Anti-inflammatory and Immunomodulatory Effects**
Root extracts down-regulate TNF-α production in dengue-infected cellular models, suggesting modulation of pro-inflammatory cytokine cascades that contribute to dengue hemorrhagic pathology and systemic inflammation.
**Antipyretic Properties**
In rodent models, Cissampelos pareira extracts demonstrate fever-reducing activity, consistent with the plant's long-standing Ayurvedic use for malaria-associated and dengue-associated febrile illness, though precise mechanistic pathways in fever reduction remain incompletely characterized.
**Menstrual Regulation in Traditional Medicine**
Indigenous Amazonian and Ayurvedic practitioners use abuta root decoctions as a uterine tonic and emmenagogue, attributed historically to smooth-muscle-modulating alkaloids including tetrandrine-class bisbenzylisoquinolines with established calcium channel antagonist properties in other pharmacological contexts.
**Broad-Spectrum Alkaloid Richness**
UPLC-DAD-ESI-QTOF-MS/MS profiling of root hydroethanolic extracts detected 30 compounds with 15 identified, indicating a complex phytochemical matrix in which synergistic alkaloid interactions may contribute to overall bioactivity beyond any single isolated compound.
Origin & History
Natural habitat
Cissampelos pareira is a woody climbing vine indigenous to tropical and subtropical regions spanning South America, South and Southeast Asia, and parts of Africa, thriving in humid lowland forests, forest margins, and disturbed habitats up to approximately 1,500 meters elevation. In Amazonian South America, it grows prolifically in Peru, Brazil, and Bolivia, where it is harvested from wild populations rather than cultivated commercially. The roots, which contain the highest concentrations of bioactive alkaloids, are the primary plant part collected by traditional healers and used in phytopharmaceutical extraction.
“Cissampelos pareira has a multi-millennial history of medicinal use across geographically distinct traditional medicine systems, most prominently in Indian Ayurveda—where it is classified as 'Patha' and employed for fevers, malaria, urinary disorders, and snake envenomation—and in Amazonian indigenous traditions spanning Peru, Bolivia, and Brazil, where abuta root is a core herb for female reproductive complaints including menstrual irregularity, uterine hemorrhage, and difficult labor. In South American ethnobotany, abuta is sometimes called the 'midwives' herb' or 'velvet leaf,' reflecting its central role in women's reproductive healthcare among communities without access to pharmaceutical medicine. Raintree Nutrition's Tropical Plant Database has catalogued over 38 alkaloids historically identified in the plant, and colonial-era botanical expeditions documented its use by indigenous Peruvian healers as early as the 17th century. Traditional preparations universally prioritize the root as the most potent plant part, prepared as aqueous decoctions, macerated in alcohol, or dried and powdered, with dosing guided by practitioner experience rather than standardized protocols.”Traditional Medicine
Scientific Research
The published evidence base for Cissampelos pareira is limited almost entirely to in vitro and small animal preclinical studies, with no registered or completed human clinical trials identified in the available literature. Antiplasmodial data derive from well-controlled in vitro bioassays using standardized P. falciparum strains (chloroquine-sensitive Pf3D7 and resistant PfINDO), with root hydroethanolic extract IC50 of 1.15–1.42 μg/ml and isolated hayatinine IC50 of 0.41–0.51 μM representing pharmacologically meaningful potency thresholds. Antiviral data in DENV-infected mice (250 mg/kg twice daily, 5-day treatment) showed statistically significant survival benefit (~67% vs. placebo, p=0.021), but sample sizes were not reported and independent replication has not been confirmed in the accessible literature. Short-term rodent toxicity studies (2 g/kg oral for 1 week in Wistar rats) showed no observed adverse effects, but the absence of chronic toxicology, pharmacokinetic, or human safety data substantially limits translational confidence.
Preparation & Dosage
Traditional preparation
**Traditional Root Decoction**
Roots are simmered in water for 20–30 minutes; traditionally consumed as 1–2 cups daily in Amazonian and Ayurvedic practice, though no standardized human dose exists.
**Hydroethanolic Extract (Research Standard)**
Root material extracted with ethanol-water mixtures; used in antiplasmodial studies at IC50 1.15–1.42 μg/ml in vitro; equivalent human dose not established.
**Alcoholic Root Extract (Antiviral Studies)**
250 mg/kg twice daily in mice; direct human dose conversion is not validated and should not be extrapolated without clinical pharmacokinetic data
Ethanol-based root extract used in dengue studies at .
**Ethyl Acetate Fraction**
Active antiplasmodial fraction with IC50 4.0 μg/ml (Pf3D7); used in fractionation research but not available as a consumer supplement form.
**Standardization**
No commercial standardization specifications (e.g., percent total alkaloids or hayatinine content) have been established or validated; products claiming standardization should be scrutinized for supporting analytical data.
**Timing**
No clinical pharmacokinetic data exist to inform optimal dosing timing or frequency in humans.
Nutritional Profile
Cissampelos pareira root is not a significant source of macronutrients or conventional micronutrients and is consumed in pharmacological rather than nutritional quantities. Its primary bioactive constituents are isoquinoline alkaloids (aporphine-type: magnoflorine, magnocurarine, salutaridine; protoberberine-type: cissamine; bisbenzylisoquinoline: tetrandrine, hayatinine, pareirarine), with UPLC-MS/MS profiling identifying 15 compounds from 30 detected peaks in root hydroethanolic extracts, though absolute concentrations per gram of dried root have not been published. Secondary metabolites including flavonoids, tannins, and sterols may be present based on broad phytochemical screening reported in regional literature, but quantified data are unavailable. Bioavailability of the alkaloid fraction is expected to vary significantly by extraction solvent polarity, with hydroethanolic and ethyl acetate fractions recovering the most bioactive alkaloid sub-fractions in comparative extraction studies.
How It Works
Mechanism of Action
The antiplasmodial activity of Cissampelos pareira root extracts is primarily attributed to isoquinoline alkaloids—especially hayatinine—that interfere with Plasmodium falciparum intraerythrocytic replication, though the precise molecular target (e.g., heme polymerization inhibition or mitochondrial electron transport disruption) has not yet been definitively resolved in published literature. Antiviral activity against dengue virus operates via a post-entry mechanism: alcoholic root extracts reduce NS1 antigen secretion and inhibit plaque formation across all four DENV serotypes, and concurrently suppress TNF-α cytokine production, suggesting interference with viral RNA replication machinery or host-cell signaling pathways activated after viral internalization. Tetrandrine, a bisbenzylisoquinoline alkaloid documented in Cissampelos pareira, is known from parallel pharmacological research to act as an L-type calcium channel blocker and NF-κB pathway inhibitor, providing a plausible mechanistic framework for observed anti-inflammatory and smooth-muscle-modulatory effects. No specific receptor-binding kinetics, enzyme inhibition constants, or gene expression data have been published for the whole-plant extracts or the full alkaloid panel in the available peer-reviewed literature on this species.
Clinical Evidence
No human clinical trials evaluating Cissampelos pareira for any indication have been published or identified in current literature searches, meaning all clinical inferences must be extrapolated cautiously from preclinical models. The most robustly characterized outcomes are antiplasmodial IC50 values from in vitro P. falciparum assays and a single in vivo dengue mouse survival study with a statistically significant but methodologically incomplete report (p=0.021, sample size unreported). Antipyretic effects and short-term safety at 2 g/kg have been documented in Wistar rat models without significant organ toxicity, providing a preliminary safety anchor for higher-dose animal studies. The aggregate preclinical profile justifies hypothesis-generation for future Phase I or ethnopharmacological validation trials, but no effect-size estimates applicable to human supplementation can be responsibly derived from current data.
Safety & Interactions
Short-term oral administration of Cissampelos pareira root extract at 2 g/kg body weight for one week produced no detectable toxicity in Wistar rats, and in vitro platelet function assays showed no adverse platelet effects at 2–10 μg/ml, providing a preliminary preclinical safety signal. No human safety data, maximum tolerated dose studies, or chronic toxicology profiles have been published, meaning the safety margin in clinical populations remains entirely undetermined. No formal drug interaction studies exist; however, given the calcium channel antagonist properties attributed to tetrandrine-class alkaloids present in the plant, theoretical pharmacodynamic interactions with antihypertensive drugs (particularly calcium channel blockers and beta-blockers) and anticoagulants warrant caution. Use during pregnancy is contraindicated based on the plant's traditional classification as an emmenagogue and uterine stimulant, and use during lactation should also be avoided until human safety data are available; individuals with liver disease, those on immunosuppressant therapy, or those scheduled for surgery should consult a qualified healthcare provider before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Cissampelos pareiraPathaVelvet LeafMidwives' HerbLaghu PathaIce Vine
Frequently Asked Questions
What is abuta root used for traditionally?
Abuta root (Cissampelos pareira) has been used for centuries in Amazonian indigenous medicine primarily as a uterine tonic and menstrual regulator, earning it the common name 'midwives' herb.' In Indian Ayurveda, it is classified as 'Patha' and traditionally prescribed for malaria, fevers, urinary tract disorders, and snake envenomation, with the root decoction being the most widely used preparation across both traditions.
Does abuta have scientifically proven health benefits?
Preclinical evidence supports antiplasmodial and antiviral activity: the isolated alkaloid hayatinine achieved IC50 values of 0.41–0.51 μM against Plasmodium falciparum in vitro, and alcoholic root extracts inhibited all four dengue serotypes with IC50 values of 78–125 μg/ml. However, no human clinical trials have been conducted, so no health benefit can be considered clinically proven for human use at this time.
What are the active compounds in abuta (Cissampelos pareira)?
The primary bioactive compounds are isoquinoline alkaloids, including hayatinine, magnocurarine, cissamine, magnoflorine, salutaridine, and pareirarine, as well as the bisbenzylisoquinoline alkaloid tetrandrine. A 2023 UPLC-DAD-ESI-QTOF-MS/MS analysis of root hydroethanolic extracts detected 30 compounds, of which 15 were identified and 5 were quantified, with hayatinine exhibiting the highest antiplasmodial potency among isolated fractions.
Is abuta safe to take as a supplement?
Short-term animal studies show no toxicity in Wistar rats at 2 g/kg body weight for one week, but no human safety data exist. The plant contains alkaloids with uterine-stimulating properties, making it contraindicated during pregnancy, and potential interactions with calcium channel blocker medications and anticoagulants cannot be excluded given the pharmacological profile of tetrandrine-class alkaloids present in the root.
What is the recommended dosage of abuta root extract?
No standardized human dosage for abuta root extract has been established, as clinical pharmacokinetic and dose-finding studies in humans have not been conducted. Animal studies used 250 mg/kg twice daily in dengue mouse models, but direct conversion to human equivalent doses is not validated; traditional preparations involve 1–2 cups of root decoction daily, though this reflects ethnobotanical practice rather than evidence-based dosing guidance.
What does research show about abuta's effectiveness against malaria?
In vitro studies have identified hayatinine, an alkaloid isolated from abuta root, as a potent antimalarial compound with IC50 values of 0.41 μM against Plasmodium falciparum PfINDO strain and 0.509 μM against Pf3D7 strain. Hayatinine demonstrated superior antimalarial activity compared to other co-isolated alkaloids from the plant, such as magnocurarine and cissamine, suggesting abuta root as a promising source for antimalarial drug development. However, these findings are limited to laboratory studies and have not yet been translated into clinical human trials.
Does abuta root extract have antiviral properties?
Preliminary research indicates that alcoholic extracts derived from abuta root exhibit antiviral activity, with studies exploring potential applications against dengue virus. While these initial findings are promising for traditional use in tropical regions where dengue is endemic, further research is needed to establish the clinical efficacy and mechanisms of action in human subjects. The antiviral potential of abuta represents an emerging area of phytopharmacological investigation.
Which alkaloid in abuta root is considered most bioactive?
Hayatinine is the primary alkaloid of interest in abuta root, demonstrating the strongest pharmacological activity in antimalarial and antiviral research models. While abuta also contains other alkaloids including magnocurarine and cissamine, hayatinine has shown superior potency in inhibiting Plasmodium growth in laboratory conditions. The concentration and bioavailability of hayatinine may vary depending on plant source, growing conditions, and extraction method used in supplement preparation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w abuta-cissampelos-pareira curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
